Physician profile
Ebony Copeland
NPI 1548404031
$57,518.82
in general payments reported to CMS, 2019-2025
13 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $13K · 2021: $7,922 · 2022: $7,785 · 2023: $2,206 · 2024: $4,671 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,639 · Travel and Lodging: $1,073 · Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,638.90 |
| Travel and Lodging | $1,072.54 |
| Food and Beverage | $385.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26,151.05 | 2019-2021 | |
| Organon LLC | $17,247.61 | 2021-2024 | Nexplanon |
| Gilead Sciences, INC. | $13,676.58 | 2019-2025 | |
| Janssen Biotech, INC. | $119.53 | 2019-2020 | |
| Novo Nordisk INC | $56.51 | 2019 | |
| Theratechnologies INC. | $52.65 | 2019-2021 | |
| Pfizer INC. | $48.75 | 2019 | |
| Dynavax Technologies Corporation | $43.98 | 2019-2023 | Heplisav-B |
| Emd Serono, INC. | $36.08 | 2019 | |
| Viiv Healthcare Company | $26.92 | 2024 | Apretude |
| Amarin Pharma, INC. | $22.66 | 2019 | |
| Glaxosmithkline, LLC. | $20.78 | 2025 | Penmenvy, Bexsero |
| Coopersurgical, INC. | $15.72 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebony Copeland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.